Organigram Holdings Inc. (TSE:OGI – Get Free Report) insider Beena Goldenberg sold 28,242 shares of the business’s stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of C$2.49, for a total transaction of C$70,322.58. Following the completion of the transaction, the insider owned 111,063 shares of the company’s stock, valued at C$276,546.87. The trade was a 20.27% decrease in their ownership of the stock.
Beena Goldenberg also recently made the following trade(s):
- On Thursday, October 30th, Beena Goldenberg sold 20,058 shares of Organigram stock. The stock was sold at an average price of C$2.25, for a total transaction of C$45,130.50.
Organigram Price Performance
Shares of TSE OGI traded down C$0.05 during trading hours on Friday, hitting C$2.11. 117,363 shares of the stock were exchanged, compared to its average volume of 176,953. The company’s fifty day simple moving average is C$2.43 and its two-hundred day simple moving average is C$2.11. The company has a market cap of C$282.50 million, a PE ratio of 175.83, a price-to-earnings-growth ratio of 0.42 and a beta of 2.16. The company has a debt-to-equity ratio of 3.07, a quick ratio of 2.62 and a current ratio of 3.36. Organigram Holdings Inc. has a 1-year low of C$1.22 and a 1-year high of C$2.89.
About Organigram
Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.
Featured Articles
- Five stocks we like better than Organigram
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- 3 Under-the-Radar AI Stocks to Buy on the Dip
- 3 Healthcare Dividend Stocks to Buy
- Your Thanksgiving Playbook: 3 Stocks Set to Benefit From Football Fever
- How to Profit From Growth Investing
- MarketBeat Week in Review – 11/10 – 11/14
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.
